NasdaqGS - Delayed Quote USD

Diversified Healthcare Trust (DHC)

2.3800 -0.0300 (-1.24%)
At close: April 25 at 4:00 PM EDT
Loading Chart for DHC
DELL
  • Previous Close 2.4100
  • Open 2.3400
  • Bid 2.3600 x 400
  • Ask 2.4100 x 300
  • Day's Range 2.3400 - 2.3950
  • 52 Week Range 0.8000 - 3.9600
  • Volume 699,979
  • Avg. Volume 1,118,369
  • Market Cap (intraday) 572.195M
  • Beta (5Y Monthly) 2.10
  • PE Ratio (TTM) --
  • EPS (TTM) -1.2300
  • Earnings Date May 6, 2024 - May 10, 2024
  • Forward Dividend & Yield 0.04 (1.68%)
  • Ex-Dividend Date Apr 19, 2024
  • 1y Target Est 3.50

DHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2023, DHC's approximately $7.2 billion portfolio included 371 properties in 36 states and Washington, D.C., occupied by approximately 500 tenants, and totaling approximately 8.6 million square feet of life science and medical office properties and more than 27,000 senior living units. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $41 billion in assets under management as of December 31, 2023 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA.

www.dhcreit.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DHC

Performance Overview: DHC

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DHC
35.86%
S&P 500
5.84%

1-Year Return

DHC
154.81%
S&P 500
22.03%

3-Year Return

DHC
42.35%
S&P 500
20.77%

5-Year Return

DHC
66.02%
S&P 500
72.46%

Compare To: DHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DHC

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    572.20M

  • Enterprise Value

    3.14B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.40

  • Price/Book (mrq)

    0.24

  • Enterprise Value/Revenue

    2.23

  • Enterprise Value/EBITDA

    15.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -20.82%

  • Return on Assets (ttm)

    -0.93%

  • Return on Equity (ttm)

    -11.80%

  • Revenue (ttm)

    1.41B

  • Net Income Avi to Common (ttm)

    -293.57M

  • Diluted EPS (ttm)

    -1.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.94M

  • Total Debt/Equity (mrq)

    121.55%

  • Levered Free Cash Flow (ttm)

    130.06M

Research Analysis: DHC

Analyst Price Targets

2.00
3.50 Average
2.3800 Current
5.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: DHC

Fair Value

2.3800 Current
 

Dividend Score

0 Low
DHC
Sector Avg.
100 High
 

Hiring Score

0 Low
DHC
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
DHC
Sector Avg.
100 High
 

Research Reports: DHC

  • DHC: Lowering target price to $0.64

    DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.640000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • DHC: Lowering target price to $0.79

    DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.792000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • DHC: Lowering target price to $0.83

    DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.832000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     
  • DHC: Lowering target price to $0.91

    DIVERSIFIED HEALTHCARE TRUST has an Investment Rating of SELL; a target price of $0.912000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Low; and a Value Subrating of Low.

    Rating
    Price Target
     

People Also Watch